请问马来酸伊索拉定的原研厂家是哪个？
是日本的那家吗？
哪位手头有pharmaprojects的能帮忙查一下。～～～～
伊索拉定(irsogladine，商品名：Gaslon)是胃粘膜保护剂，由日本新药株式会社中央研究所研制，1989年在日本上市。
百度一搜就出来了
百度查到的内容地球人都知道啦。
因为从销售的方式和情况看，日本新药株式会社不像是原研厂家，所以才想通过Pharmaprojects这一类比较权威的渠道证实一下。
帮你找了,自己看吧!
Irsogladine is a once-daily benzoguanamine derivative with antiulcer and diuretic activity, developed by Nippon Shinyaku.
Marketing
It is launched as Gaslon-N in Japan (1989) and in China (Company communication, Jun 1995). It is licensed to Taejoon Pharm, S Korea, for S Korea where a registration filing is planned for 2007 (Direct communication, Nippon Shinyaku, 7 Feb 2003; Pharma Koreana, Aug 2006). It was awaiting approval for the additional indication of gastritis (Scrip, 1993, 1877, 14).
了！！！
Nippon Shinyaku Co Ltd ，的确是日本新药株式会社
是日本的那家吗？
哪位手头有pharmaprojects的能帮忙查一下。～～～～
伊索拉定(irsogladine，商品名：Gaslon)是胃粘膜保护剂，由日本新药株式会社中央研究所研制，1989年在日本上市。
百度一搜就出来了
百度查到的内容地球人都知道啦。
因为从销售的方式和情况看，日本新药株式会社不像是原研厂家，所以才想通过Pharmaprojects这一类比较权威的渠道证实一下。
帮你找了,自己看吧!
Irsogladine is a once-daily benzoguanamine derivative with antiulcer and diuretic activity, developed by Nippon Shinyaku.
Marketing
It is launched as Gaslon-N in Japan (1989) and in China (Company communication, Jun 1995). It is licensed to Taejoon Pharm, S Korea, for S Korea where a registration filing is planned for 2007 (Direct communication, Nippon Shinyaku, 7 Feb 2003; Pharma Koreana, Aug 2006). It was awaiting approval for the additional indication of gastritis (Scrip, 1993, 1877, 14).
了！！！
Nippon Shinyaku Co Ltd ，的确是日本新药株式会社